Table 4.
Multivariate analysis of DFS and OS of 56 patients with UCB.
| Variables | HR | 95% CI | P value |
|---|---|---|---|
| Disease-free survival (DFS) | |||
| Age (≥65 versus <65 years) | 1.7 | 0.6–4.8 | 0.29 |
| Tumor stage (MI versus NMI)a | 1.6 | 0.6–4.4 | 0.38 |
| Tumor grade (G2-3 versus G1) | 1.5 | 0.5–9.8 | 0.49 |
| Survivin expression (high versus low) | 3.2 | 0.4–24.5 | 0.26 |
| Overall survival (OS) | |||
| Age (≥65 versus <65 years) | 1.8 | 0.8–17.6 | 0.08 |
| Tumor stage (MI versus NMI)a | 2.9 | 0.8–9.9 | 0.10 |
| Tumor grade (G2-3 versus G1) | 2.1 | 0.6–10.1 | 0.46 |
| Survivin expression (high versus low) | 12.3 | 1.5–98.4 | 0.02 |
aMI: muscle-invasive; NMI: non-muscle-invasive.